Furuta_2010_Diabetes.Obes.Metab_12_421

Reference

Title : Chronic administration of DSP-7238, a novel, potent, specific and substrate-selective DPP IV inhibitor, improves glycaemic control and beta-cell damage in diabetic mice - Furuta_2010_Diabetes.Obes.Metab_12_421
Author(s) : Furuta Y , Horiguchi M , Sugaru E , Ono-Kishino M , Otani M , Sakai M , Masui Y , Tsuchida A , Sato Y , Takubo K , Hochigai H , Kimura H , Nakahira H , Nakagawa T , Taiji M
Ref : Diabetes Obes Metab , 12 :421 , 2010
Abstract : Furuta_2010_Diabetes.Obes.Metab_12_421
ESTHER : Furuta_2010_Diabetes.Obes.Metab_12_421
PubMedSearch : Furuta_2010_Diabetes.Obes.Metab_12_421
PubMedID: 20415690

Related information

Citations formats

Furuta Y, Horiguchi M, Sugaru E, Ono-Kishino M, Otani M, Sakai M, Masui Y, Tsuchida A, Sato Y, Takubo K, Hochigai H, Kimura H, Nakahira H, Nakagawa T, Taiji M (2010)
Chronic administration of DSP-7238, a novel, potent, specific and substrate-selective DPP IV inhibitor, improves glycaemic control and beta-cell damage in diabetic mice
Diabetes Obes Metab 12 :421

Furuta Y, Horiguchi M, Sugaru E, Ono-Kishino M, Otani M, Sakai M, Masui Y, Tsuchida A, Sato Y, Takubo K, Hochigai H, Kimura H, Nakahira H, Nakagawa T, Taiji M (2010)
Diabetes Obes Metab 12 :421